Mineral-induced lung disease in modern industry: Part 2: Sensitizing metals

Clinical Pulmonary Medicine

Volumn 13, Issue 2, 2006, Pages 103-110

  Davis, Gerald S ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Berylliosis; Beryllium; Chronic beryllium disease; Cobalt; Epidemiology; Hard metal disease; Pneumoconiosis; Prevalence

Indexed keywords

ASBESTOS FIBER; BERYLLIUM; COAL; COBALT; HLA ANTIGEN CLASS 2; METAL; MINERAL FIBER; SILICON DIOXIDE; T LYMPHOCYTE RECEPTOR; TALC;

ARTICLE; BERYLLIOSIS; CANCER RISK; CELLULAR IMMUNITY; CONTACT DERMATITIS; DEVELOPING COUNTRY; GENETIC PREDISPOSITION; HLA SYSTEM; HUMAN; INDUSTRIAL HYGIENE; INDUSTRIALIZATION; INDUSTRY; LUNG CANCER; LUNG DISEASE; METAL INDUSTRY; MINERAL INDUCED LUNG DISEASE; OCCUPATIONAL EXPOSURE; PNEUMOCONIOSIS; SENSITIZATION;

EID: 33745678541     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cpm.0000203740.29258.29     Document Type: Article

References (79)

1. Preuss OP, Rossman MD. Clinical picture and non-immunologic laboratory findings in chronic beryllium disease. In: Rossman MD, Preuss OP, Powers MB, eds. Beryllium: Biomedical and Environmental Aspects. Baltimore: Williams & Wilkins, 1991:133-140.
2. Aronchick JM, Rossman MD, Miller WT. Chronic beryllium disease: diagnosis, radiographic findings, and correlation with pulmonary function tests. Radiology. 1987;163:677-682.
3. Harris KM, McConnochie K, Adams H. The computed tomographic appearances in chronic berylliosis. Clin Radiol. 1993;47:26-31.
4. Naccache JM, Marchand-Adam S, Kambouchner M, et al. Ground-glass computed tomography pattern in chronic beryllium disease: pathologic substratum and evolution. J Comput Assist Tomogr. 2003;27:496-500.
5. Maier LA. Clinical approach to chronic beryllium disease and other nonpneumoconiotic interstitial lung diseases. J Thorac Imaging. 2002;17:273-284.
6. Newman LS, Buschman DL, Newell JD Jr, et al. Beryllium disease: assessment with CT. Radiology. 1994;190:835-840.
7. Ferris BG Jr. Pulmonary function in patients with beryllium intoxication. AMA Arch Ind Health. 1959;19:146-149.
8. Kriebel D, Sprince NL, Eisen EA, et al. Beryllium exposure and pulmonary function: a cross sectional study of beryllium workers. Br J Ind Med. 1988;45:167-173.
9. Kriebel D, Sprince NL, Eisen EA, et al. Pulmonary function in beryllium workers: assessment of exposure. Br J Ind Med. 1988;45:83-92.
10. Butnor KJ, Sporn TA, Ingram P, et al. Beryllium detection in human lung tissue using electron probe X-ray microanalysis. Mod Pathol. 2003;16:1171-1177.
11. Newman LS. Metals. In: Harber P, Schenker MB, Balmes JR, eds. Occupational and Environmental Respiratory Disease. St. Louis, MO: Mosby, 1996:469-513.
12. Berlin JM, Taylor JS, Sigel JE, et al. Beryllium dermatitis. J Am Acad Dermatol. 2003;49:939-941.
13. Tinkle SS, Antonini JM, Rich BA, et al. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect. 2003;111:1202-1208.
14. Fontenot AP, Maier LA, Canavera SJ, et al. Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung. J Immunol. 2002;168:3627-3634.
15. Ward E, Okun A, Ruder A, et al. A mortality study of workers at seven beryllium processing plants. Am J Ind Med. 1992;22:885-904.
16. Sanderson WT, Ward EM, Steenland K, et al. Lung cancer case-control study of beryllium workers. Am J Ind Med. 2001;39:133-144.
17. International Agency for Research on Cancer. Beryllium and beryllium compounds, www.iarc.fr 58, 41. August 22, 1997.
18. Brown SC, Schonbeck MF, McClure D, et al. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats Plant: a case-control study. Am J Epidemiol. 2004;160:163-172.
19. MacMahon B. The epidemiological evidence on the carcinogenicity of beryllium in humans. J Occup Med. 1994;36:15-24.
20. Levy PS, Roth HD, Hwang PM, et al. Beryllium and lung cancer: a reanalysis of a niosh cohort mortality study. Inhal Toxicol. 2002;14:1003-1015.
21. Rossman MD, Kern JA, Elias JA, et al. Proliferative response of bronchoalveolar lymphocytes to beryllium: a test for chronic beryllium disease. Ann Intern Med. 1988;108:687-693.
22. Saltini C, Winestock K, Kirby M, et al. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med. 1989;320:1103-1109.
23. Tinkle SS, Kittle LA, Schumacher BA, et al. Beryllium induces IL-2 and IFN-gamma in berylliosis. J Immunol. 1997;158:518-526.
24. Saltini C, Richeldi L, Losi M, et al. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J. 2001;18:677-684.
25. Fontenot AP, Canavera SJ, Gharavi L, et al. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest. 2002;110:1473-1482.
26. Sawyer RT, Day BJ, Fadok VA, et al. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol. 2004;31:470-477.
27. Amicosante M, Sanarico N, Berretta F, et al. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69. Hum Immunol. 2001;62:686-693.
28. Amicosante M, Berretta F, Franchi A, et al. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells. Eur Respir J. 2002;20:1174-1178.
29. + T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. PNAS. 2000;97:12717-12722.
30. Fontenot AP, Newman LS, Kotzin BL. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP [Review]. Clin Immunol. 2001;100:4-14.
31. Lombardi G, Germain C, Uren J, et al. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J Immunol. 2001;166:3549-3555.
32. Rossman MD, Stubbs J, Lee CW, et al. Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med. 2002;165:788-794.
33. McCanlies EC, Ensey JS, Schuler CR, et al. The association between HLA-DPB1(Glu69) and chronic beryllium disease and beryllium sensitization. Am J Ind Med. 2004;46:95-103.
34. Maier LA, McGrath DS, Sato H, et al. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol. 2003;171:6910-6918.
35. Fontenot AP, Kotzin BL, Comment CE, et al. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease. Am J Respir Cell Mol Biol. 1998;18:581-589.
36. Fontenot AP, Falta MT, Freed BM, et al. Identification of pathogenic T cells in patients with beryllium-induced lung disease. J Immunol. 1999;163:1019-1026.
37. Tinkle SS, Newman LS. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Am J Respir Crit Care Med. 1997;156:1884-1891.
38. Maier LA, Sawyer RT, Bauer RA, et al. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med. 2001;164:1192-1199.
39. + T cells is mediated by HLA-DP. Am J Respir Cell Mol Biol. 2004;31:122-130.
40. Newman LS, Orton R, Kreiss K Serum angiotensin converting enzyme activity in chronic beryllium disease. Am Rev Respir Dis. 1992;146:39-42.
41. Maier LA, Raynolds MV, Young DA, et al. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med. 1999;159:1342-1350.
42. Frome EL, Newman LS, Cragle DL, et al. Identification of an abnormal beryllium lymphocyte proliferation test. Toxicology. 2003;183:39-56.
43. Barna BP, Culver DA, Yen-Lieberman B, et al. Clinical application of beryllium lymphocyte proliferation testing. Clin Diagn Lab Immunol. 2003;10:990-994.
44. Oak Ridge Associated Universities. Former Beryllium Workers Medical Surveillance Program. www.orau.gov/cer/BMSP_pro/be-home.htm. 2004.
45. Van Ordstrand HS, Hughes R, Carmody MG. Chemical pneumonia in workers extracting beryllium oxide: report of three cases. Cleve Clin Q. 1943;10:10.
46. Hardy HL, Tabershaw IR. Delayed chemical pneumonitis in workers exposed to beryllium compounds. J Ind Hyg Tox. 1946;28:197.
47. U.S. Department of Labor. OS&HA Standards. U.S. Department of Labor, 2004.
48. 3. Am J Indust Med. 1996;30:16-25.
49. Henneberger PK, Cumro D, Deubner DD, et al. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Internat Arch Occup Environ Health. 2001;74:167-176.
50. Leonard A, Lauwerys R. Mutagenicity, carcinogenicity and teratogenicity of cobalt metal and cobalt compounds. Mutat Res. 1990;239:17-27.
51. Figueroa S, Gerstenhaber B, Welch L, et al. Hard metal interstitial pulmonary disease associated with a form of welding in a metal parts coating plant. Am J Ind Med. 1992;21:363-373.
52. Shedd KB. Cobalt. U.S. Geological Survey Minerals Yearbook. Washington, DC: U.S. Government, 2001;20:1-20.11.
53. Lison D, Lauwerys R, Demedts M, et al. Experimental research into the pathogenesis of cobalt/hard metal lung disease. Eur Respir J. 1996;9:1024-1028.
54. Nemery B, Lewis CP, Demedts M. Cobalt and possible oxidant-mediated toxicity. Sci Total Environ. 1994;150:57-64.
55. Kusaka Y, Nakano Y, Shirakawa T, et al. Lymphocyte transformation with cobalt in hard metal asthma. Ind Health. 1989;27:155-163.
56. Potolicchio I, Mosconi G, Forni A, et al. Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DP beta chain. Eur J Immunol. 1997;27:2741-2743.
57. Potolicchio I, Festucci A, Hausler P, et al. HLA-DP molecules bind cobalt: a possible explanation for the genetic association with hard metal disease. Eur J Immunol. 1999;29:2140-2147.
58. Kraus T, Schramel P, Schaller KH, et al. Exposure assessment in the hard metal manufacturing industry with special regard to tungsten and its compounds. Occup Environ Med. 2001;58:631-634.
59. Kumagai S, Kusaka Y, Goto S. Cobalt exposure level and variability in the hard metal industry of Japan. Am Indust Hyg Assoc J. 1996;57:365-369.
60. Kumagai S, Kusaka Y, Goto S. Log-normality of distribution of occupational exposure concentrations to cobalt. Ann Occup Hyg. 1997;41:281-286.
61. Linnainmaa M, Kangas J, Kalliokoski P. Exposure to airborne metals in the manufacture and maintenance of hard metal and stellite blades. Am Indust Hyg Assoc J. 1996;57:196-201.
62. Linnainmaa M, Kiilunen M.Urinary cobalt as a measure of exposure in the wet sharpening of hard metal and stellite blades. Int Arch Occup Environ Health. 1997;69:193-200.
63. Mosconi G, Bacis M, Leghissa P, et al. Occupational exposure to metallic cobalt in the Province of Bergamo: results of a 1991 survey. Sci Total Environ. 1994;150:121-128.
64. Sprince NL, Oliver LC, Eisen EA, et al. Cobalt exposure and lung disease in tungsten carbide production: a cross-sectional study of current workers. Am Rev Respir Dis. 1988;138:1220-1226.
65. Auchincloss JH, Abraham JL, Gilbert R, et al. Health hazard of poorly regulated exposure during manufacture of cemented tungsten carbides and cobalt. Br J Ind Med. 1992;49:832-836.
66. Agostini C, Meneghin A, Semenzato G. T-lymphocytes and cytokines in sarcoidosis. Curr Opin Pulm Med. 2002;8:435-440.
67. Nemery B, Casier P, Roosels D, et al. Survey of cobalt exposure and respiratory health in diamond polishers. Am Rev Respir Dis. 1992;145:610-616.
68. Linna A, Oksa P, Palmroos P, et al. Respiratory health of cobalt production workers. Am J Indust Med. 2003;44:124-132.
69. Christensen JM, Poulsen OM. A 1982-1992 surveillance programme on Danish pottery painters: biological levels and health effects following exposure to soluble or insoluble cobalt compounds in cobalt blue dyes. Sci Total Environ. 1994;150:95-104.
70. Linnainmaa M, Susitaival P, Makela P, et al. Respiratory symptoms and dermatoses among grinders and brazers of hard metal and stellite blades. Occup Med (Oxf). 1997;47:33-39.
71. Kusaka Y, Iki M, Kumagai S, et al. Decreased ventilatory function in hard metal workers. Occup Environ Med. 1996;53:194-199.
72. Kusaka Y, Iki M, Kumagai S, et al. Epidemiological study of hard metal asthma. Occup Environ Med. 1996;53:188-193.
73. Kanerva L, Jolanki R, Estlander T, et al. Incidence rates of occupational allergic contact dermatitis caused by metals. Am J Contact Dermatol. 2000;11:155-160.
74. Kiec-Swierczynska M. Occupational allergic contact dermatitis in Lodz: 1990-1994. Occup Med (Oxf). 1996;46:205-208.
75. al Sheikh OA, Gad el-Rab MO. Allergic contact dermatitis: clinical features and profile of sensitizing allergens in Riyadh, Saudi Arabia. Int J Dermatol. 1996;35:493-497.
76. Bangha E, Elsner P. Sensitizations to allergens of the European standard series at the Department of Dermatology in Zurich 1990-1994. Dermatology. 1996;193:17-21.
77. Moulin JJ, Wild P, Romazini S, et al. Lung cancer risk in hard-metal workers. Am J Epidemiol. 1998;148:241-248.
78. Tuchsen F, Jensen MV, Villadsen E, et al. Incidence of lung cancer among cobalt-exposed women. Scand J Work Environ Health. 1996;22:444-450.
79. International Agency for Research on Cancer. Cobalt in hard-metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide. IARC Monogr Eval Carcinog Risk Chem Hum. 86:7-14.